Neonatal and Congenital Anomaly Neurosurgery Program
The Boston Children's Hospital Neonatal and Congenital Anomaly Neurosurgery Program was created to diagnose and treat neurologic anomalies as early as possible so that these patients have the greatest chance of experiencing optimal development and leading healthy full, healthy lives.
About our director: Benjamin Warf, MD
Dr. Warf received his medical degree from Harvard University. He began his career in pediatric neurosurgery at Boston Children's Hospital in 1991 as the first Pediatric Fellow in Neurological Surgery. From Children’s, he took a position at University of Kentucky where he became Chief of Pediatric Neurosurgery.
In 2000, Dr. Warf and his family moved to Uganda to help found a hospital for pediatric neurosurgery with CURE International, a non-profit Christian medical mission organization. While at CURE, he served as Medical Director and established the only pediatric neurosurgery hospital in Sub-Saharan Africa.
Dr. Warf was the first to identify neonatal infection as the chief cause of pediatric hydrocephalus in a developing country, and remains involved in working to uncover its pathogenesis in order to ultimately construct prevention strategies. He developed a novel surgical technique for treating hydrocephalus in infants, combining endoscopic third ventriculostomy with bilateral choroid plexus cauterization (ETV/CPC).
Since returning to the United States, DrWarf has investigated the role of ETV/CPC in North American infants, and also continues to work in international neurosurgery development. From 2006 to 2009, Dr. Warf was neurosurgeon at Dupont Hospital for Children in Wilmington, Delaware. He rejoined the team at Children’s Boston in 2009.
Read more about Dr. Warf:
- New hope for infants with hydrocephalus
- Children's doctor improves hydrocephalus treatment in Africa
- The strain of childhood illness